Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
2021 · Nature Immunology · 166 citations
https://doi.org/10.1038/s41590-021-00943-z
C
Cyril Seillet
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
5.3K
Citations
30
h-index
42
i10-index
Cyril Seillet is an academic researcher from Walter and Eliza Hall Institute of Medical Research. The author has contributed to research in topics: Immune Cell Function and Interaction & IL-33, ST2, and ILC Pathways & Eosinophilic Esophagitis. The author has an h-index of 30, co-authored 54 publications.
ORCID: 0000-0002-0941-8679Papers by this author
worksId2 represses E2A-mediated activation of IL-10 expression in T cells
2014 · Blood · 30 citations
https://doi.org/10.1182/blood-2014-03-561456
A protocol to isolate bone marrow innate lymphoid cells for alymphoid mouse reconstitution
2022 · STAR Protocols · 1 citations
https://doi.org/10.1016/j.xpro.2022.101534
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat